Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug ‘Stempeucel®’

- The First Company in the World to be Granted a Japanese Process Patent for a Stem Cell Drug Based on Pooling Technology – A New Treatment Which Offers Hope for Patients Suffering From Critical Limb Ischemia (CLI) – Offers New Hope to Millions of Patients …

[Read the full article here]

Comments are closed.